stdClass Object
(
    [id] => 16523
    [paper_index] => 202506-01-022375
    [title] => A STUDY TOWARD PUBLIC AWARENESS OF GENERIC DRUGS FOR SAFETY AND AFFORDABILITY IN HEALTHCARE
    [description] => 
    [author] => Mark Dakshin Kennedy, Dr. Rashmi Shetty
    [googlescholar] => 
    [doi] => https://doi.org/10.36713/epra22375
    [year] => 2025
    [month] => June
    [volume] => 11
    [issue] => 6
    [file] => fm/jpanel/upload/2025/June/202506-01-022375.pdf
    [abstract] => This study examines the Public Awareness and Usage of Generic Drugs (ALGM) and its relationship with four key factors: Factors Influencing Awareness of Generic Drugs (FIAGD), Factors Influencing Awareness of Brand-Name Drugs (FIABND), Role of Healthcare Professionals (RHPE), and Barriers & Misconceptions about Generic Drugs (BMGD). Using Descriptive Statistics, Reliability Analysis, and Regression Analysis, the study investigates whether these independent variables significantly influence public engagement with generic medications.
Descriptive statistics reveal moderate to high mean scores across all factors, with ALGM showing the highest mean (3.47), indicating a general but varied level of awareness and usage among the population. The reliability analysis confirms strong internal consistency (Cronbach’s Alpha = 0.865). Regression analysis results suggest that FIAGD, FIABND, and RHPE have a positive and statistically significant impact on ALGM (p < 0.05), while BMGD shows a negative influence, highlighting misconceptions as a barrier to acceptance. The model explains a substantial portion of the variance in ALGM, indicating the importance of these predictors in shaping public perception and behavior.
The findings suggest that targeted awareness campaigns, healthcare professional involvement, and myth-busting initiatives could significantly improve public acceptance of generic drugs. Future research could include demographic variables, expand to rural populations, and incorporate longitudinal data to assess awareness trends over time.
This study contributes to public health literature by offering quantitative evidence on the behavioral and perceptual drivers of generic drug usage, with actionable insights for healthcare stakeholders and policymakers.

    [keywords] => Generic Drugs, Brand-Name Drugs, Public Awareness, Misconceptions, Healthcare Professionals
    [doj] => 2025-06-13
    [hit] => 
    [status] => 
    [award_status] => P
    [orderr] => 76
    [journal_id] => 1
    [googlesearch_link] => 
    [edit_on] => 
    [is_status] => 1
    [journalname] => EPRA International Journal of Multidisciplinary Research (IJMR)
    [short_code] => IJMR
    [eissn] =>  2455-3662 (Online)
    [pissn] => - --
    [home_page_wrapper] => images/products_image/11.IJMR.png
)
Error fetching PDF file.